These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21296240)
1. Off-label use of antibiotics in intensive care unit: the multidrug-resistant pathogens challenge. Curcio D J Crit Care; 2011 Feb; 26(1):95-6. PubMed ID: 21296240 [No Abstract] [Full Text] [Related]
2. [Justification of off-label antibiotics uses in hospitalized children]. Berthod C; Kassaï B; Boussageon R; ; Adelaide L; Jacquet-Lagrèze M; Lajoinie A Therapie; 2017 Dec; 72(6):649-658. PubMed ID: 28647107 [TBL] [Abstract][Full Text] [Related]
4. Frequency of the off-label use of antibiotics in clinical practice: a systematic review. Tansarli GS; Rafailidis PI; Kapaskelis A; Falagas ME Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1383-92. PubMed ID: 23253317 [TBL] [Abstract][Full Text] [Related]
5. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit. Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504 [TBL] [Abstract][Full Text] [Related]
7. Off-label drug use: the bevacizumab story. Stewart MW Mayo Clin Proc; 2013 Mar; 88(3):305. PubMed ID: 23489456 [No Abstract] [Full Text] [Related]
8. Just Say "Stop": Avoiding Prolonged Empiric Antibiotics. Rimawi RH Crit Care Med; 2015 Dec; 43(12):2675-6. PubMed ID: 26575654 [No Abstract] [Full Text] [Related]
9. Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012. Almalki ZS; Alahmari AK; Guo JJ; Cavanaugh TM Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1042-51. PubMed ID: 27133913 [TBL] [Abstract][Full Text] [Related]
11. Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing. Kesselheim AS; Woloshin S; Lu Z; Tessema FA; Ross KM; Schwartz LM JAMA Intern Med; 2019 May; 179(5):707-709. PubMed ID: 30667474 [TBL] [Abstract][Full Text] [Related]
12. Treatment Indications for Antidepressants Prescribed in Primary Care in Quebec, Canada, 2006-2015. Wong J; Motulsky A; Eguale T; Buckeridge DL; Abrahamowicz M; Tamblyn R JAMA; 2016 May 24-31; 315(20):2230-2. PubMed ID: 27218634 [No Abstract] [Full Text] [Related]
13. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic. Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925 [TBL] [Abstract][Full Text] [Related]
14. Off label or on trend: a review of the use of quetiapine in New Zealand. Huthwaite M; Tucker M; McBain L; Romans S N Z Med J; 2018 May; 131(1474):45-50. PubMed ID: 29723178 [No Abstract] [Full Text] [Related]
15. Struggles Over Antibiotics: Physicians' Stance-Taking Toward a Nonconforming Policy in an Intensive Care Unit. Caronia L; Saglietti M Qual Health Res; 2017 Nov; 27(13):2006-2018. PubMed ID: 28810817 [TBL] [Abstract][Full Text] [Related]
16. Off-label paediatric drug use in an Indonesian community setting. Abdulah R; Khairinisa MA; Pratiwi AA; Barliana MI; Pradipta IS; Halimah E; Diantini A; Lestari K J Clin Pharm Ther; 2015 Aug; 40(4):409-12. PubMed ID: 25884353 [TBL] [Abstract][Full Text] [Related]
17. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU). Jobanputra N; Save SU; Bavdekar SB Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245 [TBL] [Abstract][Full Text] [Related]
18. USE OF OFF-LABEL MEDICATIONS IN A NEONATAL INTENSIVE CARE UNIT. Koszma EIA; Bispo AJB; Santana IAO; Santos CNODBD Rev Paul Pediatr; 2021; 39():e2020063. PubMed ID: 33440406 [TBL] [Abstract][Full Text] [Related]
19. Off-label use of antibiotics in hospitalized patients: focus on tigecycline. Curcio D J Antimicrob Chemother; 2009 Dec; 64(6):1344-6. PubMed ID: 19759045 [No Abstract] [Full Text] [Related]
20. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital. Kannan S; Bahl A; Khosla PP Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]